Skip to main content
Clinical Trials/NCT03114449
NCT03114449
Completed
Not Applicable

Auricular Acupuncture (AA) vs. Sham AA Procedure for Pain Control After Elective Knee Arthroplasty - a Randomized Controlled Trial

University Medicine Greifswald0 sites150 target enrollmentOctober 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
University Medicine Greifswald
Enrollment
150
Primary Endpoint
Postoperative requirement of analgesic tilidine (measured in mg)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Aim of the study To investigate whether auricular acupuncture (AA) will reduce postoperative pain and analgesic requirement in comparison with sham AA in patients after elective knee arthroplasty

Design Prospective randomized controlled blinded clinical trial

Participants:

  • Patients < 80 und > 50 years old
  • scheduled for knee arthroplasty under general anesthesia with < 120 minutes duration
  • Without previous opioid medication
  • Able to give informed consent

Outcome measures

  • Postoperative analgesic requirement
  • Incidence of side effects
  • Physiological parameters
Registry
clinicaltrials.gov
Start Date
October 2012
End Date
December 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Medicine Greifswald
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with an American Society of Anesthesiologists physical status of I to III scheduled for elective knee arthroplasty under general anesthesia
  • Surgery time does not exceed 120 minutes
  • Patients without previous opioid medication
  • Patients ranged 50-80 years old
  • Patients who have given written informed consent

Exclusion Criteria

  • Recidivist alcoholics
  • Local auricular skin infection
  • Age \< 50 and \> 80 years
  • Surgery time more than 120 minutes
  • Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines)
  • Patients who consumed opioid medication at least 6 months before surgery
  • Patients with prosthetic or damaged cardiac valves, intracardiac and intravascular shunts, hypertrophic cardiomyopathy and mitral valve prolaps (risk of bacterial endocarditis according to guidelines of AHA)
  • Patients who are unable to understand the consent form
  • History of psychiatric disease

Outcomes

Primary Outcomes

Postoperative requirement of analgesic tilidine (measured in mg)

Time Frame: Six days following surgery

Requirement of opioid analgesic tilidin

Secondary Outcomes

  • blood pressure(12 hours following surgery)
  • Patients' satisfaction with the treatment of postoperative pain using NRS-5 (where 1=excellent; 5=very bad)(12 hours following surgery)
  • Side effects of analgesics(Six days following surgery)
  • heart rate(12 hours after surgery)

Similar Trials